OPRM1 and schizophrenia: While structurally similar to the opioid receptor antagonist naltrexone, samidorphan is more efficacious for treating schizophrenia due to its affinity being five times greater at mu-opioid receptors and its increased oral bioavailability as compared to naltrexone [45].